2018 Korean Guideline of Atrial Fibrillation Management
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joung, Boyoung | - |
dc.contributor.author | Lee, Jung Myung | - |
dc.contributor.author | Lee, Ki Hong | - |
dc.contributor.author | Kim, Tae-Hoon | - |
dc.contributor.author | Choi, Eue-Keun | - |
dc.contributor.author | Lim, Woo-Hyun | - |
dc.contributor.author | Kang, Ki-Woon | - |
dc.contributor.author | Shim, Jaemin | - |
dc.contributor.author | Lim, Hong Euy | - |
dc.contributor.author | Park, Junbeom | - |
dc.contributor.author | Lee, So-Ryoung | - |
dc.contributor.author | Lee, Young Soo | - |
dc.contributor.author | Kim, Jin-Bae | - |
dc.date.accessioned | 2021-09-02T02:20:17Z | - |
dc.date.available | 2021-09-02T02:20:17Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/71276 | - |
dc.description.abstract | Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population. The Korean Heart Rhythm Society organized a Korean AF Management Guideline Committee and analyzed all available studies regarding the management of AF, including studies on Korean patients. This guideline is based on recent data of the Korean population and the recent guidelines of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery, American Heart Association, and Asia Pacific Heart Rhythm Society. Expert consensus or guidelines for the optimal management of Korean patients with AF were achieved after a systematic review with intensive discussion. This article provides general principles for appropriate risk stratification and selection of anticoagulation therapy in Korean patients with AF. This guideline deals with optimal stroke prevention, screening, rate and rhythm control, risk factor management, and integrated management of AF. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CARDIOLOGY | - |
dc.subject | ADHERENT ANTITHROMBOTIC TREATMENT | - |
dc.subject | VITAMIN-K ANTAGONIST | - |
dc.subject | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject | CONGESTIVE-HEART-FAILURE | - |
dc.subject | RENIN-ANGIOTENSIN SYSTEM | - |
dc.subject | PLACEBO-CONTROLLED TRIAL | - |
dc.subject | RADIOFREQUENCY CATHETER ABLATION | - |
dc.subject | STROKE RISK STRATIFICATION | - |
dc.subject | TRANSIENT ISCHEMIC ATTACK | - |
dc.subject | TYPE-2 DIABETES-MELLITUS | - |
dc.title | 2018 Korean Guideline of Atrial Fibrillation Management | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shim, Jaemin | - |
dc.contributor.affiliatedAuthor | Lim, Hong Euy | - |
dc.identifier.doi | 10.4070/kcj.2018.0339 | - |
dc.identifier.scopusid | 2-s2.0-85056720283 | - |
dc.identifier.wosid | 000450739200001 | - |
dc.identifier.bibliographicCitation | KOREAN CIRCULATION JOURNAL, v.48, no.12, pp.1033 - 1080 | - |
dc.relation.isPartOf | KOREAN CIRCULATION JOURNAL | - |
dc.citation.title | KOREAN CIRCULATION JOURNAL | - |
dc.citation.volume | 48 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1033 | - |
dc.citation.endPage | 1080 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002402535 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | ADHERENT ANTITHROMBOTIC TREATMENT | - |
dc.subject.keywordPlus | VITAMIN-K ANTAGONIST | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | CONGESTIVE-HEART-FAILURE | - |
dc.subject.keywordPlus | RENIN-ANGIOTENSIN SYSTEM | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | RADIOFREQUENCY CATHETER ABLATION | - |
dc.subject.keywordPlus | STROKE RISK STRATIFICATION | - |
dc.subject.keywordPlus | TRANSIENT ISCHEMIC ATTACK | - |
dc.subject.keywordPlus | TYPE-2 DIABETES-MELLITUS | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Anticoagulants | - |
dc.subject.keywordAuthor | Therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.